Quantcast

Latest biotechnology Stories

2014-06-25 16:24:11

Report Released at 2014 BIO International Convention Explores Important Changes to Patent Process SAN DIEGO, June 25, 2014 /PRNewswire/ -- Bloomberg BNA and law firm Robins, Kaplan, Miller, & Ciresi L.L.P, in conjunction with the Biotechnology Industry Organization, today published a study on the impact of recent U.S. Supreme Court decisions affecting the life sciences industry. The report, Stopped at the Threshold: The Practical Implications of the Supreme Court's Mayo and...

2014-06-25 12:30:18

HLI Co-Founder, Robert Hariri Speaks on Medical Innovation at 2014 BIO International Convention in San Diego LA JOLLA, Calif., June 25, 2014 /PRNewswire/ -- Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today called on physicians, the insurance industry and political leaders to support promising new avenues of medical discovery on behalf of patients with...

2014-06-25 08:32:07

SAN DIEGO, June 25, 2014 /PRNewswire/ -- Concortis Biosystems, Inc. (Concortis), a subsidiary of Sorrento Therapeutics (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated pain, today announced a collaboration to generate novel antibody drug conjugates (ADCs) based on a Morphotek antibody linked to chemotherapeutic agents using Concortis' proprietary ADC Technology. Under the terms of the agreement, Sorrento will receive...

2014-06-25 04:20:56

GOSSELIES, Belgium, June 25, 2014 /PRNewswire/ -- Minimally invasive bone forming product ALLOB(R)in Phase I/IIa trial for delayed union fracture Bone Therapeutics, the regenerative therapy company addressing unmet medical needs in the field of bone diseases and orthopaedics, today announces that the first patient has been treated with its novel allogeneic osteoblastic (bone-forming) cell therapy product ALLOB(R) in its phase...

2014-06-24 23:07:47

Today, in his keynote address at the Cell Science-2014 4th World Congress on Cell Science and Stem Cell Research in Valencia, Spain, Dr. James L. Sherley, Director of ASCTC, LLC, announced the June 24 issue of the company's newly approved patent for a method to produce iPSCs with a single non-genetic agent. The new technology – based on an underlying biological connection between adult tissue stem cells and iPSCs – has potential to provide a convenient and general method for...

2014-06-24 23:03:05

New research report “Cancer Cell Therapy Market & Pipeline Insight” elaborated by Kuick Research is now available at MarketPublishers.com London, UK (PRWEB) June 24, 2014 Over the past 5 years, the world cancer cell therapy market witnessed strong growth. Furthermore, this market is expected to keep on following an upward trend in the years ahead, driven by the increasing cancer incidence worldwide, rising adoption of novel drugs, high unmet needs along with the continuously...

2014-06-24 16:24:19

President Leigh Pierce to be a Featured Speaker in Multi-Disciplinary Industry Forum SAN DIEGO, June 24, 2014 /PRNewswire/ -- PacificGMP is a lead sponsor of the California Pavilion at BIO International Convention, June 23-26, 2014 in San Diego, California. The biologics contract development and manufacturer will be available for meetings at Booth 3523 in Hall A of the California Pavilion. On Tuesday, June 24(th) at 3 p.m., PacificGMP President and Chief Scientific Officer Leigh Pierce will...

2014-06-24 10:42:09

RIKEN Stem cells have the unique ability to become any type of cell in the body. Given this, the possibility that they can be cultured and engineered in the laboratory makes them an attractive option for regenerative medicine. However, some conditions that are commonly used for culturing human stem cells have the potential to introduce contaminants, thus rendering the cells unusable for clinical use. These conditions cannot be avoided, however, as they help maintain the pluripotency of...

2014-06-24 08:30:32

CAMBRIDGE, Mass., June 24, 2014 /PRNewswire/ -- Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. today announced a three-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration, Janssen scientists will work with the research team at Dana-Farber's Belfer Institute for Applied Cancer Science to determine the clinical setting for certain immuno-oncology agents in Janssen's lung cancer discovery pipeline. "We are...

2014-06-24 08:29:37

CAMBRIDGE, England, June 24, 2014 /PRNewswire/ -- Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization, and provides proprietary products and novel services for this rapidly-growing market. The Company has now just secured $2.3 million in a First Close of a new investment round. The latter will finally complete in early September 2014 with more potential funding already in the pipeline. "This is the first tranche of funding that...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »
Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related